4 results
Evaluating the long term safety and tolerability of ranibizumab treatment of AMD patients.
The objective of this study is to obtain clinical performance (outcomes) data and survivorship for commercially available Zimmer Persona knee implants implanted in primary total knee arthroplasty.
The primary objective of the study is to determine the efficacy of AP26113, as evidenced by objective response rate, in patients with ALK positive locally advanced or metastatic NSCLC whose disease has progressed on therapy with crizotinib.
The objective of this study is to obtain clinical performance (outcomes) data andsurvivorship for commercially available Zimmer Persona knee implants implanted inprimary total knee arthroplasty.